Medicolegal Considerations with Intravenous Tissue Plasminogen Activator in Stroke: A Systematic Review

Medicolegal Considerations with Intravenous Tissue Plasminogen Activator in Stroke: A Systematic Review

Background. Intravenous tPA (tissue plasminogen activator) therapy remains underutilized in patients with Acute Ischemic Stroke (AIS). Anecdotal data indicates that physicians are increasingly liable for administering and for failure to administer tPA. Methods. An extensive search of Medline, Embase...

Full description

Saved in:

Bibliographic Details
Main Authors:	Archit Bhatt, Adnan Safdar, Dhara Chaudhari, Diane Clark, Amber Pollak, Arshad Majid, Mounzer Kassab
Format:	Article
Language:	English
Published:	Wiley 2013-01-01
Series:	Stroke Research and Treatment
Online Access:	http://dx.doi.org/10.1155/2013/562564
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cerebral arterial collateral status, but not venous outflow profiles, modifies the effect of intravenous tissue plasminogen activator in acute ischemic stroke
by: Elif Sarionder Gencer, et al.
Published: (2024-12-01)

Angioedema Secondary to IV Tissue Plasminogen Activator Administration for Treatment of Acute Ischemic Stroke
by: Benjamin Chaucer, et al.
Published: (2018-01-01)

Adjudication of Fibromyalgia Syndrome: Challenges in the Medicolegal Arena
by: Mary-Ann Fitzcharles, et al.
Published: (2014-01-01)

Tissue Plasminogen Activator Toxicity after Submacular Hemorrhage Repair
by: Yasmin Islam, et al.
Published: (2021-07-01)

Medicolegal and Ethical Perspectives in the Use of Narcoanalysis in Criminal Investigations in India
by: Vina Vaswani, et al.
Published: (2024-05-01)

Impact of the biopsychosocial model of disability on the medicolegal assessment of personal injury
by: Isabelle Lutte, et al.
Published: (2024-12-01)

Medicolegal aspects of medical malpractice claims following aesthetic interventions in Cairo, Egypt
by: Ghada Abdelwahed Rawash, et al.
Published: (2025-02-01)

Functional Stability of Plasminogen Activator Inhibitor-1
by: Songul Yasar Yildiz, et al.
Published: (2014-01-01)

Use of the Recombinant Tissue Plasminogen Activator in the Management of Complex Infected Intraperitoneal Fluid Collection
by: Aibek E. Mirrakhimov, et al.
Published: (2019-01-01)

Prevalence of latent tuberculosis and mycobacterial infections in medicolegal cases with pleural adhesions: An observational study
by: Jayanthi Yadav, et al.
Published: (2025-07-01)

Pharmaceutical, Pharmacokinetic and Other Considerations for Intravenous to Oral Stepdown Therapy
by: Peter J Jewesson
Published: (1995-01-01)

Is Intravenous Heparin a Contraindication for TPA in Ischemic Stroke?
by: Zain Kulairi, et al.
Published: (2017-01-01)

Intersigmoid Hernia: A Forgotten Diagnosis—A Systematic Review of the Literature over Anatomical, Diagnostic, Surgical, and Medicolegal Aspects
by: Stella Chiarini, et al.
Published: (2020-01-01)

Multivitamin Supplementation and Fertility Outcome: A Retrospective Single-Center Cohort Study and the Clinical and Medicolegal Value of Nutritional Counseling
by: Giuseppe Gullo, et al.
Published: (2025-01-01)

Intraocular Lens Opacification following Intracameral Injection of Recombinant Tissue Plasminogen Activator to Treat Inflammatory Membranes after Cataract Surgery
by: Simon S. M. Fung, et al.
Published: (2015-01-01)

Evaluation of Retinal Pigment Epithelial Cell Cytotoxicity of Recombinant Tissue Plasminogen Activator Using Human-Induced Pluripotent Stem Cells
by: Hiroyuki Kamao, et al.
Published: (2019-01-01)

Vitrectomy with subretinal tissue plasminogen activator and intravitreal injection of bevacizumab in the treatment of submacular haemorrhage secondary to wet AMD – case series
by: Agnieszka Nowosielska, et al.
Published: (2024-03-01)

Enoxaparin Effect on Pregnancy Outcomes in a Patient with Elevated Plasminogen Activator Inhibitor-1
by: Kathleen Minor, et al.
Published: (2020-01-01)

Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects
by: Sándor Somodi, et al.
Published: (2018-01-01)

Repeated intravenous thrombolysis in early recurrent stroke due to free-floating thrombus
by: Luis Eduardo Borges de Macedo Zubko, et al.
Published: (2025-01-01)

Safe Implementation of Treatments in Stroke: a study on intravenous thrombolysis in patients over 80 years of age with acute ischaemic stroke
by: Manju Krishnan, et al.
Published: (2025-01-01)

The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis
by: Fei Huang, et al.
Published: (2020-01-01)

Plasminogen Activator Inhibitor-1 Regulates LPS Induced Inflammation in Rat Macrophages through Autophagy Activation
by: Zhong-Hui Wang, et al.
Published: (2014-01-01)

Role of plasminogen/plasmin system components and matrix metalloproteases in retinal artery occlusion following cardiac surgery
by: L.V. Natrus, et al.
Published: (2024-12-01)

Ureteral Dilatation with No Apparent Cause on Intravenous Urography: Normal or Abnormal? A Pilot Study
by: Vinita Rathi, et al.
Published: (2015-01-01)

Plasma plasminogen activator inhibitor-1 as a predictive marker of type 2 diabetic nephropathy in Egyptian patients
by: El-Saeid M.E.-S. El-Bawab, et al.
Published: (2023-07-01)

Clinical value of soluble urokinase-type plasminogen activator receptor in predicting sepsis-associated acute kidney injury
by: Wenwen Zhang, et al.
Published: (2024-12-01)

Development and validation of an explainable machine learning prediction model of hemorrhagic transformation after intravenous thrombolysis in stroke
by: Yanan Lin, et al.
Published: (2025-01-01)

Group a Streptococcus remains viable inside fibrin clots and gains access to human plasminogen for subsequent fibrinolysis and dissemination
by: Henry M. Vu, et al.
Published: (2025-02-01)

Acute Oxalate Nephropathy Associated with Orlistat: A Case Report with a Review of the Literature
by: Dhara Chaudhari, et al.
Published: (2013-01-01)

Permeable Pavement Systems: Technical Considerations
by: Eban Bean, et al.
Published: (2019-04-01)

Permeable Pavement Systems: Technical Considerations
by: Eban Bean, et al.
Published: (2019-04-01)

Efficacy of Intravenous Tenecteplase Bridge Thrombectomy for Recurrent Ischemic Stroke Within 3 Months: A Case Report
by: Liu C, et al.
Published: (2025-02-01)

Safety and efficacy of intravenous thrombolysis: a systematic review and meta-analysis of 93,057 minor stroke patients
by: Mostafa Hossam El Din Moawad, et al.
Published: (2025-01-01)

Following intravenous thrombolysis, the outcome of diabetes mellitus associated with acute ischemic stroke was predicted via machine learning
by: Xiaoqing Liu, et al.
Published: (2025-01-01)

Age-related features of some plasminogen activation system components content and activity in the blood of benign and malignant uterine body tumors
by: I. V. Kaplieva, et al.
Published: (2024-09-01)

Study the effect of urokinase-type plasminogen activator (UPA) and some biochemical parameters in Iraqi hemodialysis patients with type 2 diabetes
by: Fatima Ali Essa Al-Sudani, et al.
Published: (2024-01-01)

Effect of Depth of Total Intravenous General Anesthesia on Intraoperative Electrically Evoked Compound Action Potentials in Cochlear Implantation Surgery
by: Ala”a Alhowary, et al.
Published: (2019-01-01)

Intravenous Administration of Adipose-Derived Stem Cell Protein Extracts Improves Neurological Deficits in a Rat Model of Stroke
by: Kai Zhao, et al.
Published: (2017-01-01)

The joint effects of inflammation and renal function status on in-hospital outcomes in patients with acute ischemic stroke treated with intravenous thrombolysis
by: Zhichao Huang, et al.
Published: (2024-12-01)